Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02073279
Brief Title: Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

First Submitted : February 25, 2014
First Submitted that Met QC Criteria : February 25, 2014
First Posted : February 27, 2014 (Estimate)

Results First Submitted : September 11, 2020
Results First Submitted that Met QC Criteria : December 7, 2020
Results First Posted : December 31, 2020

Certification/Extension First Submitted : June 5, 2019
Certification/Extension First Submitted that Met QC Criteria : June 5, 2019
Certification/Extension First Posted : June 7, 2019

Last Update Submitted that Met QC Criteria : March 22, 2021
Last Update Posted : March 24, 2021